As nanotechnology companies continue to develop tiny, microscopic products to support scientific, medical and communications needs, their financial support could explode to enormous levels if they decide to go public.

Arrowhead Research, a Pasadena, Calif.-based, public investment company, is backed by mutual fund giant Fidelity Investments and the hedge fund company York Capital Management, according to the International Herald Tribune.

Subscribe Now

Access to premium content including in-depth coverage of mutual funds, hedge funds, 401(K)s, 529 plans, and more.

3-Week Free Trial

Insight and analysis into the management, marketing, operations and technology of the asset management industry.